Frank, N.; Dickinson, D.; Lovett, G.; Liu, Y.; Yu, H.; Cai, J.; Yao, B.; Jiang, X.; Hsu, S.
Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment. Pharmaceutics 2024, 16, 791.
https://doi.org/10.3390/pharmaceutics16060791
AMA Style
Frank N, Dickinson D, Lovett G, Liu Y, Yu H, Cai J, Yao B, Jiang X, Hsu S.
Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment. Pharmaceutics. 2024; 16(6):791.
https://doi.org/10.3390/pharmaceutics16060791
Chicago/Turabian Style
Frank, Nicolette, Douglas Dickinson, Garrison Lovett, Yutao Liu, Hongfang Yu, Jingwen Cai, Bo Yao, Xiaocui Jiang, and Stephen Hsu.
2024. "Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment" Pharmaceutics 16, no. 6: 791.
https://doi.org/10.3390/pharmaceutics16060791
APA Style
Frank, N., Dickinson, D., Lovett, G., Liu, Y., Yu, H., Cai, J., Yao, B., Jiang, X., & Hsu, S.
(2024). Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment. Pharmaceutics, 16(6), 791.
https://doi.org/10.3390/pharmaceutics16060791
